Tag: TMS
FDA Clears Deep TMS™ for Adolescents With Major Depressive Disorder
The FDA has cleared BrainsWay’s Deep TMS™ system as an adjunct treatment for adolescents aged 15–21 with major depressive disorder, expanding access to a noninvasive, evidence-based therapy previously available only to adults.
Upcoming Events
Webinar Replays
Member Login
Our Audience
eMHIC has and audience of 12 member countries (and growing) with thousands of subscribers around the world.
Share your thoughts
Have quality news or resources to share on the eMHIC Knowledge Bank? We’d love to consider publishing them for our global community.
